Extracellular ribonucleic acids (RNA) enter the stage in cardiovascular disease

Circulation Research

Volumn 118, Issue 3, 2016, Pages 469-479

  Zernecke, Alma ^a   Preissner, Klaus T ^b  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Atherosclerosis; Inflammation; Myocardial infarction; Reperfusion injury; Thrombosis

Indexed keywords

NUCLEIC ACID; RIBONUCLEASE; RIBOSOME RNA; RNA; GENETIC MARKER;

ANGIOGENESIS; ATHEROSCLEROSIS; BLOOD CLOTTING; BLOOD VESSEL PERMEABILITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR INFLAMMATION; CELL ACTIVATION; CEREBROVASCULAR ACCIDENT; CYTOKINE RESPONSE; DISEASE ASSOCIATION; ENDOTHELIUM CELL; HEART INFARCTION; HUMAN; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; REVIEW; THROMBOSIS; ANIMAL; GENE EXPRESSION REGULATION; GENETIC MARKER; GENETICS; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; CARDIOVASCULAR DISEASES; GENE EXPRESSION REGULATION; GENETIC MARKERS; HUMANS; RNA; SIGNAL TRANSDUCTION;

EID: 84958554963     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.115.307961     Document Type: Review

References (100)

1. Chan JK, Roth J, Oppenheim JJ, Tracey KJ, Vogl T, Feldmann M, Horwood N, Nanchahal J. Alarmins: Awaiting a clinical response. J Clin Invest. 2012;122:2711-2719. doi:10.1172/JCI62423.
2. Mandel P, Metais P. Les acides nucléiques du plasma sanguin chez l'homme. C R Seances Soc Biol Fil. 1948;142:241-243.
3. Tan EM, Schur PH, Carr RI, Kunkel HG. Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. J Clin Invest. 1966;45:1732-1740doi:10.1172/JCI105479.
4. Gould TJ, Lysov Z, Liaw PC. Extracellular DNA and histones: doubleedged swords in immunothrombosis. J Thromb Haemost. 2015;13(suppl 1):S82-S91. doi:10.1111/jth.12977.
5. Fuchs TA, Brill A, Wagner DD. Neutrophil extracellular trap (NET) impact on deep vein thrombosis. Arterioscler Thromb Vasc Biol. 2012;32:1777- 1783. doi:10.1161/ATVBAHA.111.242859.
6. Mangold A, Alias S, Scherz T, et al. Coronary neutrophil extracellular trap burden and deoxyribonuclease activity in ST-elevation acute coronary syndrome are predictors of ST-segment resolution and infarct size. Circ Res. 2015;116:1182-1192. doi:10.1161/CIRCRESAHA.116.304944.
7. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, Brohi K, Itagaki K, Hauser CJ. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature. 2010;464:104-107. doi:10.1038/nature08780.
8. Wolfe RR, Song J, Sun J, Zhang XJ. Total aminoacyl-transfer RNA pool is greater in liver than muscle in rabbits. J Nutr. 2007;137:2333-2338.
9. Kopreski MS, Benko FA, Gocke CD. Circulating RNA as a tumor marker: detection of 5T4 mRNA in breast and lung cancer patient serum. Ann N Y Acad Sci. 2001;945:172-178.
10. Wieczorek AJ, Rhyner C, Block LH. Isolation and characterization of an RNA-proteolipid complex associated with the malignant state in humans. Proc Natl Acad Sci U S A. 1985;82:3455-3459.
11. Kopreski MS, Benko FA, Kwak LW, Gocke CD. Detection of tumor messenger RNA in the serum of patients with malignant melanoma. Clin Cancer Res. 1999;5:1961-1965.
12. Loyer X, Vion AC, Tedgui A, Boulanger CM. Microvesicles as cell-cell messengers in cardiovascular diseases. Circ Res. 2014;114:345-353. doi:10.1161/CIRCRESAHA.113.300858.
13. Schober A, Nazari-Jahantigh M, Weber C. MicroRNA-mediated mechanisms of the cellular stress response in atherosclerosis. Nat Rev Cardiol. 2015;12:361-374. doi:10.1038/nrcardio.2015.38.
14. Loyer X, Mallat Z, Boulanger CM, Tedgui A. MicroRNAs as therapeutic targets in atherosclerosis. Expert Opin Ther Targets. 2015;19:489-496. doi:10.1517/14728222.2014.989835.
15. Redzic JS, Balaj L, van der Vos KE, Breakefield XO. Extracellular RNA mediates and marks cancer progression. Semin Cancer Biol. 2014;28:14- 23. doi:10.1016/j.semcancer.2014.04.010.
16. Zhao WP, Liu XG, Wang W, Gao XM. Large quantity of ribosomal RNA exists extracellularly in mouse spleen. Histochem J. 2002;34:391-396.
17. Fischer S, Preissner KT. Extracellular nucleic acids as novel alarm signals in the vascular system. Mediators of defence and disease. Hamostaseologie. 2013;33:37-42. doi:10.5482/HAMO-13-01-0001.
18. Fischer S, Cabrera-Fuentes HA, Noll T, Preissner KT. Impact of extracellular RNA on endothelial barrier function. Cell Tissue Res. 2014;355:635- 645. doi:10.1007/s00441-014-1850-8.
19. Fischer S, Nishio M, Dadkhahi S, Gansler J, Saffarzadeh M, Shibamiyama A, Kral N, Baal N, Koyama T, Deindl E, Preissner KT. Expression and localisation of vascular ribonucleases in endothelial cells. Thromb Haemost. 2011;105:345-355. doi:10.1160/TH10-06-0345.
20. Cabrera-Fuentes HA, Ruiz-Meana M, Simsekyilmaz S, et al. RNase1 prevents the damaging interplay between extracellular RNA and tumour necrosis factor-α in cardiac ischaemia/reperfusion injury. Thromb Haemost. 2014;112:1110-1119. doi:10.1160/TH14-08-0703.
21. Böttcher K, Wenzel A, Warnecke JM. Investigation of the origin of extracellular RNA in human cell culture. Ann N Y Acad Sci. 2006;1075:50-56doi:10.1196/annals.1368.006.
22. Dinger ME, Mercer TR, Mattick JS. RNAs as extracellular signaling molecules. J Mol Endocrinol. 2008;40:151-159. doi:10.1677/JME-07-0160.
23. Deindl E, Fischer S, Preissner KT. New directions in inflammation and immunity: the multi-functional role of the extracellular RNA/RNase system. Indian J Biochem Biophys. 2009;46:461-466.
24. Stroun M, Anker P, Beljanski M, Henri J, Lederrey C, Ojha M, Maurice PA. Presence of RNA in the nucleoprotein complex spontaneously released by human lymphocytes and frog auricles in culture. Cancer Res. 1978;38:3546-3554.
25. Kannemeier C, Shibamiya A, Nakazawa F, et al. Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation. Proc Natl Acad Sci U S A. 2007;104:6388-6393. doi:10.1073/pnas.0608647104.
26. Fischer S, Nishio M, Peters SC, Tschernatsch M, Walberer M, Weidemann S, Heidenreich R, Couraud PO, Weksler BB, Romero IA, Gerriets T, Preissner KT. Signaling mechanism of extracellular RNA in endothelial cells. FASEB J. 2009;23:2100-2109. doi:10.1096/fj.08-121608.
27. Fischer S, Gerriets T, Wessels C, Walberer M, Kostin S, Stolz E, Zheleva K, Hocke A, Hippenstiel S, Preissner KT. Extracellular RNA mediates endothelial- cell permeability via vascular endothelial growth factor. Blood. 2007;110:2457-2465. doi:10.1182/blood-2006-08-040691.
28. Jaax ME, Krauel K, Marschall T, Brandt S, Gansler J, Fürll B, Appel B, Fischer S, Block S, Helm CA, Müller S, Preissner KT, Greinacher A. Complex formation with nucleic acids and aptamers alters the antigenic properties of platelet factor 4. Blood. 2013;122:272-281. doi:10.1182/blood-2013-01-478966.
29. Nakazawa F, Kannemeier C, Shibamiya A, Song Y, Tzima E, Schubert U, Koyama T, Niepmann M, Trusheim H, Engelmann B, Preissner KT. Extracellular RNA is a natural cofactor for the (auto-)activation of Factor VII-activating protease (FSAP). Biochem J. 2005;385:831-838. doi:10.1042/BJ20041021.
30. Vu TT, Zhou J, Leslie BA, Stafford AR, Fredenburgh JC, Ni R, Qiao S, Vaezzadeh N, Jahnen-Dechent W, Monia BP, Gross PL, Weitz JI. Arterial thrombosis is accelerated in mice deficient in histidine-rich glycoprotein. Blood. 2015;125:2712-2719. doi:10.1182/blood-2014-11-611319.
31. Wygrecka M, Morty RE, Markart P, Kanse SM, Andreasen PA, Wind T, Guenther A, Preissner KT. Plasminogen activator inhibitor-1 is an inhibitor of factor VII-activating protease in patients with acute respiratory distress syndrome. J Biol Chem. 2007;282:21671-21682. doi:10.1074/jbc.M610748200.
32. Chen X, Liang H, Zhang J, Zen K, Zhang CY. Secreted microRNAs: A new form of intercellular communication. Trends Cell Biol. 2012;22:125-132. doi:10.1016/j.tcb.2011.12.001.
33. Fichtlscherer S, Zeiher AM, Dimmeler S. Circulating microRNAs: biomarkers or mediators of cardiovascular diseases? Arterioscler Thromb Vasc Biol. 2011;31:2383-2390. doi:10.1161/ATVBAHA.111.226696.
34. Zernecke A, Bidzhekov K, Noels H, Shagdarsuren E, Gan L, Denecke B, Hristov M, Köppel T, Jahantigh MN, Lutgens E, Wang S, Olson EN, Schober A, Weber C. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal. 2009;2:ra81. doi:10.1126/scisignal.2000610.
35. Hergenreider E, Heydt S, Tréguer K, Boettger T, Horrevoets AJ, Zeiher AM, Scheffer MP, Frangakis AS, Yin X, Mayr M, Braun T, Urbich C, Boon RA, Dimmeler S. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol. 2012;14:249-256. doi:10.1038/ncb2441.
36. Skog J, Würdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, Curry WT Jr, Carter BS, Krichevsky AM, Breakefield XO. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008;10:1470-1476. doi:10.1038/ncb1800.
37. Etheridge A, Gomes CP, Pereira RW, Galas D, Wang K. The complexity, function and applications of RNA in circulation. Front Genet. 2013;4:115. doi:10.3389/fgene.2013.00115.
38. Yin M, Loyer X, Boulanger CM. Extracellular vesicles as new pharmacological targets to treat atherosclerosis. Eur J Pharmacol. 2015;763:90- 103. doi:10.1016/j.ejphar.2015.06.047.
39. Ismail N, Wang Y, Dakhlallah D, Moldovan L, Agarwal K, Batte K, Shah P, Wisler J, Eubank TD, Tridandapani S, Paulaitis ME, Piper MG, Marsh CB. Macrophage microvesicles induce macrophage differentiation and miR-223 transfer. Blood. 2013;121:984-995. doi:10.1182/blood-2011-08-374793.
40. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9:654-659. doi:10.1038/ncb1596.
41. Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol. 2008;110:13-21. doi:10.1016/j.ygyno.2008.04.033.
42. Théry C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol. 2009;9:581-593. doi:10.1038/nri2567.
43. Mittelbrunn M, Sánchez-Madrid F. Intercellular communication: diverse structures for exchange of genetic information. Nat Rev Mol Cell Biol. 2012;13:328-335. doi:10.1038/nrm3335.
44. Zhou H, Xu W, Qian H, Yin Q, Zhu W, Yan Y. Circulating RNA as a novel tumor marker: An in vitro study of the origins and characteristics of extracellular RNA. Cancer Lett. 2008;259:50-60. doi:10.1016/j.canlet.2007.09.016.
45. Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF, Mitchell PS, Bennett CF, Pogosova-Agadjanyan EL, Stirewalt DL, Tait JF, Tewari M. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A. 2011;108:5003-5008. doi:10.1073/pnas.1019055108.
46. Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol. 2011;13:423-433. doi:10.1038/ncb2210.
47. Hopkins PN. Molecular biology of atherosclerosis. Physiol Rev. 2013;93:1317-1542doi:10.1152/physrev.00004.2012.
48. Ibáñez B, Heusch G, Ovize M, Van de Werf F. Evolving therapies for myocardial ischemia/reperfusion injury. J Am Coll Cardiol. 2015;65:1454- 1471doi:10.1016/j.jacc.2015.02.032.
49. Boon RA, Hergenreider E, Dimmeler S. Atheroprotective mechanisms of shear stress-regulated microRNAs. Thromb Haemost. 2012;108:616-620. doi:10.1160/TH12-07-0491.
50. Alexy T, Rooney K, Weber M, Gray WD, Searles CD. TNF-α alters the release and transfer of microparticle-encapsulated miRNAs from endothelial cells. Physiol Genomics. 2014;46:833-840doi:10.1152/physiolgenomics.00079.2014.
51. Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C, Weber M, Hamm CW, Röxe T, Müller-Ardogan M, Bonauer A, Zeiher AM, Dimmeler S. Circulating microRNAs in patients with coronary artery disease. Circ Res. 2010;107:677-684. doi:10.1161/CIRCRESAHA.109.215566.
52. Bot I, Shi GP, Kovanen PT. Mast cells as effectors in atherosclerosis. Arterioscler Thromb Vasc Biol. 2015;35:265-271. doi:10.1161/ATVBAHA.114.303570.
53. Chen C, Feng Y, Zou L, Wang L, Chen HH, Cai JY, Xu JM, Sosnovik DE, Chao W. Role of extracellular RNA and TLR3-Trif signaling in myocardial ischemia-reperfusion injury. J Am Heart Assoc. 2014;3:e000683. doi:10.1161/JAHA.113.000683.
54. Simsekyilmaz S, Cabrera-Fuentes HA, Meiler S, Kostin S, Baumer Y, Liehn EA, Weber C, Boisvert WA, Preissner KT, Zernecke A. Response to letter regarding article "Role of extracellular RNA in atherosclerotic plaque formation in mice". Circulation. 2014;130:e144-e145. doi:10.1161/CIRCULATIONAHA.114.012346.
55. Cabrera-Fuentes HA, Lopez ML, McCurdy S, Fischer S, Meiler S, Baumer Y, Galuska SP, Preissner KT, Boisvert WA. Regulation of monocyte/macrophage polarisation by extracellular RNA. Thromb Haemost. 2015;113:473-481. doi:10.1160/TH14-06-0507.
56. Feng Y, Chen H, Cai J, Zou L, Yan D, Xu G, Li D, Chao W. Cardiac RNA induces inflammatory responses in cardiomyocytes and immune cells via Toll-like receptor 7 signaling. J Biol Chem. 2015;290:26688-26698. doi:10.1074/jbc.M115.661835.
57. Bálint Z, Zabini D, Konya V, Nagaraj C, Végh AG, Váró G, Wilhelm I, Fazakas C, Krizbai IA, Heinemann A, Olschewski H, Olschewski A. Double-stranded RNA attenuates the barrier function of human pulmonary artery endothelial cells. PLoS One. 2014;8:e63776. doi:10.1371/journal.pone.0063776.
58. Sun S, Sursal T, Adibnia Y, Zhao C, Zheng Y, Li H, Otterbein LE, Hauser CJ, Itagaki K. Mitochondrial DAMPs increase endothelial permeability through neutrophil dependent and independent pathways. PLoS One. 2013;8:e59989. doi:10.1371/journal.pone.0059989.
59. Goddard LM, Iruela-Arispe ML. Cellular and molecular regulation of vascular permeability. Thromb Haemost. 2013;109:407-415doi:10.1160/TH12-09-0678.
60. Walberer M, Tschernatsch M, Fischer S, Ritschel N, Volk K, Friedrich C, Bachmann G, Mueller C, Kaps M, Nedelmann M, Blaes F, Preissner KT, Gerriets T. RNase therapy assessed by magnetic resonance imaging reduces cerebral edema and infarction size in acute stroke. Curr Neurovasc Res. 2009;6:12-19.
61. Zhang Y, Cliff WJ, Schoefl GI, Higgins G. Plasma protein insudation as an index of early coronary atherogenesis. Am J Pathol. 1993;143:496-506.
62. Garcia-Dorado D, Andres-Villarreal M, Ruiz-Meana M, Inserte J, Barba I. Myocardial edema: A translational view. J Mol Cell Cardiol. 2012;52:931- 939. doi:10.1016/j.yjmcc.2012.01.010.
63. Sharifpanah F, De Silva S, Bekhite MM, Hurtado-Oliveros J, Preissner KT, Wartenberg M, Sauer H. Stimulation of vasculogenesis and leukopoiesis of embryonic stem cells by extracellular transfer RNA and ribosomal RNA. Free Radic Biol Med. 2015;89:1203-1217. doi:10.1016/j.freeradbiomed.2015.10.423.
64. Hannig M, Figulla HR, Sauer H, Wartenberg M. Control of leucocyte differentiation from embryonic stem cells upon vasculogenesis and confrontation with tumour tissue. J Cell Mol Med. 2010;14:303-312.
65. Schmelter M, Ateghang B, Helmig S, Wartenberg M, Sauer H. Embryonic stem cells utilize reactive oxygen species as transducers of mechanical strain-induced cardiovascular differentiation. FASEB J. 2006;20:1182- 1184. doi:10.1096/fj.05-4723fje.
66. Sauer H, Rahimi G, Hescheler J, Wartenberg M. Role of reactive oxygen species and phosphatidylinositol 3-kinase in cardiomyocyte differentiation of embryonic stem cells. FEBS Lett. 2000;476:218-223.
67. Subramaniam S, Thielmann I, Morowski M, Pragst I, Sandset PM, Nieswandt B, Etscheid M, Kanse SM. Defective thrombus formation in mice lacking endogenous factor VII activating protease (FSAP). Thromb Haemost. 2015;113:870-880. doi:10.1160/TH14-06-0519.
68. Parahuleva MS, Hölschermann H, Zandt D, Pons-Kühnemann J, Parviz B, Weiskirchen R, Staubitz A, Tillmanns H, Erdogan A, Kanse SM. Circulating factor VII activating protease (FSAP) is associated with clinical outcome in acute coronary syndrome. Circ J. 2012;76:2653-2661.
69. Kanse SM, Parahuleva M, Muhl L, Kemkes-Matthes B, Sedding D, Preissner KT. Factor VII-activating protease (FSAP): vascular functions and role in atherosclerosis. Thromb Haemost. 2008;99:286-289. doi:10.1160/TH07-10-0640.
70. von Brühl ML, Stark K, Steinhart A, et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med. 2012;209:819-835. doi:10.1084/jem.20112322.
71. Renné T, Schmaier AH, Nickel KF, Blombäck M, Maas C. In vivo roles of factor XII. Blood. 2012;120:4296-4303. doi:10.1182/blood-2012-07-292094.
72. Fischer S, Gesierich S, Griemert B, Schänzer A, Acker T, Augustin HG, Olsson AK, Preissner KT. Extracellular RNA liberates tumor necrosis factor-α to promote tumor cell trafficking and progression. Cancer Res. 2013;73:5080-5089. doi:10.1158/0008-5472.CAN-12-4657.
73. Fischer S, Grantzow T, Pagel JI, Tschernatsch M, Sperandio M, Preissner KT, Deindl E. Extracellular RNA promotes leukocyte recruitment in the vascular system by mobilising proinflammatory cytokines. Thromb Haemost. 2012;108:730-741. doi:10.1160/TH12-03-0186.
74. Manka DR, Wiegman P, Din S, Sanders JM, Green SA, Gimple LW, Ragosta M, Powers ER, Ley K, Sarembock IJ. Arterial injury increases expression of inflammatory adhesion molecules in the carotid arteries of apolipoprotein-E-deficient mice. J Vasc Res. 1999;36:372-378. doi:25676.
75. Lucerna M, Zernecke A, de Nooijer R, de Jager SC, Bot I, van der Lans C, Kholova I, Liehn EA, van Berkel TJ, Yla-Herttuala S, Weber C, Biessen EA. Vascular endothelial growth factor-A induces plaque expansion in ApoE knock-out mice by promoting de novo leukocyte recruitment. Blood. 2007;109:122-129. doi:10.1182/blood-2006-07-031773.
76. Zernecke A, Weber C. Chemokines in atherosclerosis: proceedings resumed. Arterioscler Thromb Vasc Biol. 2014;34:742-750. doi:10.1161/ATVBAHA.113.301655.
77. Dvorak AM, Morgan ES, Weller PF. RNA is closely associated with human mast cell lipid bodies. Histol Histopathol. 2003;18:943-968.
78. Blaes F, Tschernatsch M, Braeu ME, Matz O, Schmitz K, Nascimento D, Kaps M, Birklein F. Autoimmunity in complex-regional pain syndrome. Ann N Y Acad Sci. 2007;1107:168-173. doi:10.1196/annals.1381.018.
79. Karikó K, Buckstein M, Ni H, Weissman D. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity. 2005;23:165-175. doi:10.1016/j.immuni.2005.06.008.
80. Lövgren T, Eloranta ML, Båve U, Alm GV, Rönnblom L. Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum. 2004;50:1861-1872. doi:10.1002/art.20254.
81. Ganguly D, Chamilos G, Lande R, Gregorio J, Meller S, Facchinetti V, Homey B, Barrat FJ, Zal T, Gilliet M. Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J Exp Med. 2009;206:1983-1994. doi:10.1084/jem.20090480.
82. Sandgren S, Wittrup A, Cheng F, Jönsson M, Eklund E, Busch S, Belting M. The human antimicrobial peptide LL-37 transfers extracellular DNA plasmid to the nuclear compartment of mammalian cells via lipid rafts and proteoglycan-dependent endocytosis. J Biol Chem. 2004;279:17951- 17956. doi:10.1074/jbc.M311440200.
83. Marshak-Rothstein A, Busconi L, Rifkin IR, Viglianti GA. The stimulation of Toll-like receptors by nuclear antigens: A link between apoptosis and autoimmunity. Rheum Dis Clin North Am. 2004;30:559-574, ix. doi:10.1016/j.rdc.2004.04.005.
84. Döring Y, Manthey HD, Drechsler M, et al. Auto-antigenic protein- DNA complexes stimulate plasmacytoid dendritic cells to promote atherosclerosis. Circulation. 2012;125:1673-1683. doi:10.1161/CIRCULATIONAHA.111.046755.
85. Döring Y, Zernecke A. Plasmacytoid dendritic cells in atherosclerosis. Front Physiol. 2012;3:230. doi:10.3389/fphys.2012.00230.
86. Zhang Z, Meng P, Han Y, Shen C, Li B, Hakim MA, Zhang X, Lu Q, Rong M, Lai R. Mitochondrial DNA-LL-37 complex promotes atherosclerosis by escaping from autophagic recognition. Immunity. 2015;43:1137-1147. doi:10.1016/j.immuni.2015.10.018.
87. Karper JC, Ewing MM, Habets KL, de Vries MR, Peters EA, van Oeveren-Rietdijk AM, de Boer HC, Hamming JF, Kuiper J, Kandimalla ER, La Monica N, Jukema JW, Quax PH. Blocking toll-like receptors 7 and 9 reduces postinterventional remodeling via reduced macrophage activation, foam cell formation, and migration. Arterioscler Thromb Vasc Biol. 2012;32:e72-e80. doi:10.1161/ATVBAHA.112.249391.
88. Salagianni M, Galani IE, Lundberg AM, et al. Toll-like receptor 7 protects from atherosclerosis by constraining "inflammatory" macrophage activation. Circulation. 2012;126:952-962doi:10.1161/CIRCULATIONAHA.111.067678.
89. Koulis C, Chen YC, Hausding C, Ahrens I, Kyaw TS, Tay C, Allen T, Jandeleit-Dahm K, Sweet MJ, Akira S, Bobik A, Peter K, Agrotis A. Protective role for Toll-like receptor-9 in the development of atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2014;34:516-525. doi:10.1161/ATVBAHA.113.302407.
90. Ma C, Ouyang Q, Huang Z, Chen X, Lin Y, Hu W, Lin L. Toll-Like receptor 9 inactivation alleviated atherosclerotic progression and inhibited macrophage polarized to M1 phenotype in ApoE-/- mice. Dis Markers. 2015;2015:909572. doi:10.1155/2015/909572.
91. Barrabés S, Pagès-Pons L, Radcliffe CM, Tabarés G, Fort E, Royle L, Harvey DJ, Moenner M, Dwek RA, Rudd PM, De Llorens R, Peracaula R. Glycosylation of serum ribonuclease 1 indicates a major endothelial origin and reveals an increase in core fucosylation in pancreatic cancer. Glycobiology. 2007;17:388-400. doi:10.1093/glycob/cwm002.
92. Futami J, Tsushima Y, Murato Y, Tada H, Sasaki J, Seno M, Yamada H. Tissue-specific expression of pancreatic-type RNases and RNase inhibitor in humans. DNA Cell Biol. 1997;16:413-419.
93. Pavlov N, Hatzi E, Bassaglia Y, Frendo JL, Evain Brion D, Badet J. Angiogenin distribution in human term placenta, and expression by cultured trophoblastic cells. Angiogenesis. 2003;6:317-330. doi:10.1023/B:AGEN.0000029412.95244.81.
94. Leland PA, Staniszewski KE, Park C, Kelemen BR, Raines RT. The ribonucleolytic activity of angiogenin. Biochemistry. 2002;41:1343-1350.
95. Loverix S, Steyaert J. Ribonucleases: from prototypes to therapeutic targets? Curr Med Chem. 2003;10:779-785.
96. Gansler J, Preissner KT, Fischer S. Influence of proinflammatory stimuli on the expression of vascular ribonuclease 1 in endothelial cells. FASEB J. 2014;28:752-760. doi:10.1096/fj.13-238600.
97. Weickmann JL, Olson EM, Glitz DG. Immunological assay of pancreatic ribonuclease in serum as an indicator of pancreatic cancer. Cancer Res. 1984;44:1682-1687.
98. Sznajd J, Magdon M, Naskalski JW, Uracz R, Wójcikiewicz O. Serum ribonuclease activity in acute myocardial infarction. Cor Vasa. 1981;23:241-247.
99. Maciejak A, Kiliszek M, Michalak M, Tulacz D, Opolski G, Matlak K, Dobrzycki S, Segiet A, Gora M, Burzynska B. Gene expression profiling reveals potential prognostic biomarkers associated with the progression of heart failure. Genome Med. 2015;7:26. doi:10.1186/s13073-015-0149-z.
100. Heusch G. Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning. Circ Res. 2015;116:674- 699. doi:10.1161/CIRCRESAHA.116.305348.